Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10,994,020
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
164,722
-
Shares change
-
+64,104
-
Total reported value, excl. options
-
$387,355
-
Value change
-
+$164,978
-
Number of buys
-
7
-
Number of sells
-
4
-
Price
-
$2.35
Institutional Holders of Phio Pharmaceuticals Corp. - Common Stock, par value $0.0001 per share (PHIO) as of Q2 2025
As of 30 Jun 2025 Phio Pharmaceuticals Corp. - Common Stock, par value $0.0001 per share (PHIO) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 164,722 shares of stock of the company.
Largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Cetera Investment Advisers, Virtu Financial LLC, MORGAN STANLEY, Royal Bank of Canada, SBI Securities Co., Ltd., ASSETMARK, INC, BANK OF AMERICA CORP /DE/, and ELEVATION POINT WEALTH PARTNERS, LLC.
This table shows 14 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.